paige_pharma said:

They are two different exemptions from the same federal requirements and they buy different things.

paige_pharma has the substance of this right. The condition it depends on is worth stating. Worth adding the genuine exception, because it is real and narrow: a change made for an identified patient where the prescriber determines it produces a significant clinical difference for that patient. A grid of fixed doses offered to everybody is not that, whatever the intake form says.

TinaHashiRN said:

The arithmetic is right and one caveat matters: a U-40 syringe changes the markings, not the volumes.

Thank you for spelling out the reasoning rather than just the conclusion. Sending this to two other people who asked me the same thing last week.

paige_pharma said:

They are two different exemptions from the same federal requirements and they buy different things.

This is where I part company with the consensus forming above. A research-chemical supplier selling lyophilised powder labelled research use only is not compounding and is not claiming to. It is a different legal universe with no pharmacy oversight, no patient relationship and no content guarantee, and conflating the two in these threads helps nobody.

steph_laguna said:

I reconstituted a 10mg vial with 2ml of bacteriostatic water and I want someone to check my unit arithmetic before I draw anything, because I keep…

dosing arithmetic — critical reminder about tirzepatide dose equivalence across formulations:

Mounjaro KwikPen and compounded tirzepatide are the same molecule but:

• KwikPen is ready to inject, no mixing needed
• Compounded requires reconstitution and proper syringe technique
• Verify your compounded concentration before each injection
• Never assume 1 vial = 1 dose without checking the math

Moderator note: a couple of off-topic posts removed.